HomeNMRA • NASDAQ
add
Neumora Therapeutics Inc
Previous close
$1.49
Day range
$1.32 - $1.48
Year range
$1.30 - $18.61
Market cap
216.49M USD
Avg Volume
1.73M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 62.92M | 25.59% |
Net income | -58.82M | 45.90% |
Net profit margin | — | — |
Earnings per share | -0.37 | 47.89% |
EBITDA | -62.76M | -25.70% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 307.58M | -32.25% |
Total assets | 316.97M | -36.12% |
Total liabilities | 29.91M | 10.28% |
Total equity | 287.06M | — |
Shares outstanding | 161.98M | — |
Price to book | 0.84 | — |
Return on assets | -46.99% | — |
Return on capital | -51.37% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -58.82M | 45.90% |
Cash from operations | -50.34M | 2.14% |
Cash from investing | -98.80M | -822.37% |
Cash from financing | 15.57M | 3,337.63% |
Net change in cash | -133.57M | -249.23% |
Free cash flow | -29.41M | 29.73% |
About
Founded
2019
Headquarters
Website
Employees
110
